Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1975-09-12
1977-06-21
Killos, Paul J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
2602471R, 260268R, 2602948F, 260473G, 4242485, 424250, 424263, C07C 6976
Patent
active
040312402
ABSTRACT:
Mono- and diesters of 2,5-dihydroxy benzene sulfonic acid are represented by the following formula: ##STR1## wherein each R residue is hydrogen or the residue of p-chlorophenoxy isobutyric acid having the formula: ##STR2## with the proviso that both Rs are not hydrogen simultaneously, and B is hydrogen or the equivalent of an inorganic or organic cation, these compounds are remarkable for their hypocholesterolemic, hypotriglycidemic and hypolipidemic activity.
REFERENCES:
patent: 2170996 (1939-08-01), Grether et al.
patent: 3448110 (1919-06-01), Griot et al.
patent: 3546273 (1970-12-01), Bolhofer
patent: 3625950 (1971-12-01), Cragoe
Brinks Henry L.
Killos Paul J.
Laboratorios del Dr. Esteve S.A.
LandOfFree
2,5-Dihydroxy benzene sulfonic acid mono- and diesters does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,5-Dihydroxy benzene sulfonic acid mono- and diesters, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,5-Dihydroxy benzene sulfonic acid mono- and diesters will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-737018